Will tyrosine kinase inhibitors be part of the treatment armamentarium for CML in the future? Editorial Article uri icon

Overview

publication date

  • January 7, 2018

Identity

Scopus Document Identifier

  • 85041333482

Digital Object Identifier (DOI)

  • 10.1080/14656566.2017.1421633

PubMed ID

  • 29308683

Additional Document Info

volume

  • 19

issue

  • 2